Compare Novo Nordisk A/S (NVO) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Waste Management, Inc. — how do they compare? Novo Nordisk A/S trades at $45.04 (market cap $198.57B), while Waste Management, Inc. trades at $217.2 (market cap $86.51B). The key difference: Novo Nordisk A/S is far larger — about 2.3× Waste Management, Inc.'s market cap, and Novo Nordisk A/S pays the higher dividend (4.03%). Which is the better fit depends on your goals.
| NVO | WM | |
|---|---|---|
Market Cap | $198.57B | $86.51B |
Sector | Health | Industrials |
52-Week High | $63.98 | $246.51 |
52-Week Low | $35.29 | $196.77 |
Enterprise Value | $213.37B | $109.31B |
Dividend Yield | 4.03% | 1.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $45.16, down 3.09% on the day, with a bearish technical outlook. The stock shows strong fundamentals, including a P/E of 11.07, net income margin of 35.35%, and consistent earnings beats. Recent news highlights the launch of Wegovy pill in Germany and positive pediatric obesity trial results, though competition with Eli Lilly remains intense.
The outlook is mixed: strong profitability and analyst buy consensus (57.9%) support upside, but technical weakness and competitive pressures pose risks. Revenue growth is steady, with 2026 projections at $329.4B, but recent trial halts for cardiovascular drugs dim diversification prospects.
WM trades at $217.78, down 0.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed Q2 2026 earnings, beating EPS estimates at $2.02 versus $1.98 expected, but missed Q4 2025. Revenue grew to $25.20B in 2025, with a net income margin of 11.12%. Recent news highlights CEO transition and strong institutional buying, including a 26,113.1% position increase by California State Teachers Retirement System in Q2 2026.
Outlook remains positive with a consensus price target of $263.43, implying 21% upside, supported by steady waste demand and sustainability investments. Risks include high debt levels, with a debt-to-asset ratio of 49.97% in 2025, and valuation concerns at a P/E of 30.8. The stock offers a dividend yield from recent payouts, but investors face execution risks amid leadership changes and economic sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
